Business Insider4 天
Polyrizon agreement with Eurofins secures CTM for PL-14 allergy blocker trial
This collaboration will supply Clinical Trial Material, or CTM, for Polyrizon’s PL-14 allergy blocker, in preparation for a clinical trial that is expected to commence in 2025. With this ...